Blog
Experienced medical device leader joins Pearl IRB
Pearl IRB proudly announces the hiring of Patti Connolly, M.S. as Director of Clinical Services. Connolly brings over 30 years of experience in medical research across academic and industry settings, with 10 years dedicated directly to product development, clinical...
Technical issues lead to a delay of EU Clinical Trial Regulation application
The application of the clinical trial regulations has been postponed due to technical issues of the IT systems. Because of this, the EU Clinical Trial Regulation will not go into effect until 2019. The ultimate goal of the new system is to provide a single-entry port...
Pearl IRB proudly announces the completion of a clean FDA audit
Pearl IRB proudly announces the completion of a clean FDA audit. There were no significant findings during the May 2017 audit and FDA issued no 483s. Our AAHRPP accredited IRB operates in compliance with all federal and state regulations governing clinical research....
Updated clinical trial common protocol templates aim to speed up research, align objectives & endpoints
The NIH-FDA Joint Leadership Council and TransCelerate BioPharma released updated common protocol templates (CPT) last week to accelerate clinical development. An Outsourcing-Pharma.com article and interview with TransCelerate CEO, Dalvir Gill, details some of the key...
Experienced clinical research associate joins Pearl IRB
Pearl IRB is pleased to announce the hiring of Masheka Fuqua as a Clinical Research Associate (CRA) serving biopharmaceutical, medical device, and diagnostics companies. Fuqua brings over a decade of clinical research experience to Pearl Pathways, including the...